CA2869295A1 - Procedes faisant appel a la methylation de l'adn pour identifier une cellule ou un melange de cellules afin de pronostiquer et de diagnostiquer des maladies et pour effectuer des traitements de reparation cellulaire - Google Patents
Procedes faisant appel a la methylation de l'adn pour identifier une cellule ou un melange de cellules afin de pronostiquer et de diagnostiquer des maladies et pour effectuer des traitements de reparation cellulaire Download PDFInfo
- Publication number
- CA2869295A1 CA2869295A1 CA2869295A CA2869295A CA2869295A1 CA 2869295 A1 CA2869295 A1 CA 2869295A1 CA 2869295 A CA2869295 A CA 2869295A CA 2869295 A CA2869295 A CA 2869295A CA 2869295 A1 CA2869295 A1 CA 2869295A1
- Authority
- CA
- Canada
- Prior art keywords
- methylation
- dna
- cell
- cells
- cpg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/10—Ploidy or copy number detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/30—Unsupervised data analysis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/20—Supervised data analysis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Analytical Chemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Molecular Biology (AREA)
- Data Mining & Analysis (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioethics (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Software Systems (AREA)
- Evolutionary Computation (AREA)
- Artificial Intelligence (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
La présente invention concerne des procédés faisant appel à des réseaux de méthylation d'ADN pour identifier une cellule ou un mélange de cellules et pour quantifier les modifications de distribution de cellules dans le sang ou dans les tissus, et pour diagnostiquer, pronostiquer et traiter des maladies, en particulier un cancer. Les procédés utilisent des échantillons fraîchement prélevés et stockés.
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161489883P | 2011-05-25 | 2011-05-25 | |
US61/489,883 | 2011-05-25 | ||
US201161509644P | 2011-07-20 | 2011-07-20 | |
US61/509,644 | 2011-07-20 | ||
US201261585892P | 2012-01-12 | 2012-01-12 | |
US61/585,892 | 2012-01-12 | ||
US201261619663P | 2012-04-03 | 2012-04-03 | |
US61/619,663 | 2012-04-03 | ||
PCT/US2012/039699 WO2012162660A2 (fr) | 2011-05-25 | 2012-05-25 | Procédés faisant appel à la méthylation de l'adn pour identifier une cellule ou un mélange de cellules afin de pronostiquer et de diagnostiquer des maladies et pour effectuer des traitements de réparation cellulaire |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2869295A1 true CA2869295A1 (fr) | 2012-11-29 |
Family
ID=47218125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2869295A Abandoned CA2869295A1 (fr) | 2011-05-25 | 2012-05-25 | Procedes faisant appel a la methylation de l'adn pour identifier une cellule ou un melange de cellules afin de pronostiquer et de diagnostiquer des maladies et pour effectuer des traitements de reparation cellulaire |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2714933A4 (fr) |
CA (1) | CA2869295A1 (fr) |
WO (1) | WO2012162660A2 (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9561006B2 (en) * | 2008-10-15 | 2017-02-07 | The United States Of America As Represented By The Secretary Of The Navy | Bayesian modeling of pre-transplant variables accurately predicts kidney graft survival |
EP3382033B1 (fr) * | 2017-03-30 | 2020-08-05 | Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen | Méthode pour déterminer le nombre des cellules sanguines basée sur la méthylation de l'adn |
DE102017125013B4 (de) | 2017-10-25 | 2019-10-17 | Epiontis Gmbh | MCC als epigenetischer Marker zur Identifizierung von Immunzellen, insbesondere basophiler Granulozyten |
DE102017125019B4 (de) | 2017-10-25 | 2019-10-17 | Epiontis Gmbh | PDCD1 als epigenetischer Marker zur Identifizierung von Immunzellen, insbesondere PD1+ Zellen |
DE102017125150B4 (de) | 2017-10-26 | 2019-10-10 | Epiontis Gmbh | Endosialin (CD248) als epigenetischer Marker zur Identifizierung von Immunzellen, insbesondere naïver CD8+ T-Zellen |
DE102017125335B4 (de) | 2017-10-27 | 2019-10-17 | Epiontis Gmbh | Amplikon-Region als epigenetischer Marker zur Identifizierung von Immunzellen, insbesondere nicht-klassischer Monozyten |
DE102017126248B4 (de) | 2017-11-09 | 2019-10-17 | Epiontis Gmbh | ERGIC1 als epigenetischer Marker zur Identifizierung von Immunzellen, insbesonderemonozytischem myeloid-abgeleiteten Suppressor-Zellen (mMDSCs) |
DE102018112644B4 (de) | 2018-05-25 | 2020-06-10 | Epiontis Gmbh | CXCR3 als epigenetischer Marker zur Identifizierung von inflammatorischen Immunzellen, insbesondere CD8+ Gedächnis-T-Zellen |
WO2020007951A1 (fr) | 2018-07-05 | 2020-01-09 | Epiontis Gmbh | Méthode épigénétique pour détecter et faire la distinction entre des syndromes ipex et des syndromes de type ipex, en particulier chez les nouveau-nés |
DE102020108560B4 (de) | 2020-03-27 | 2022-03-03 | Precision For Medicine Gmbh | CBX6 als epigenetischer Marker für die Identifizierung von Immunzellen, insbesondere Gedächtnis-B-Zellen |
DE102020111423B4 (de) | 2020-04-27 | 2022-03-03 | Precision For Medicine Gmbh | MYH11/NDE1 Region als epigenetischer Marker für die Identifizierung von Endothel-Vorläuferzellen (EPCs) |
KR20230119130A (ko) | 2020-12-14 | 2023-08-16 | 리제너론 파마슈티칼스 인코포레이티드 | 인히빈 서브유닛 베타 e(inhbe) 억제제로 대사 장애 및 심혈관 질환을 치료하는 방법 |
CN114703284A (zh) * | 2022-04-15 | 2022-07-05 | 北京莱盟君泰国际医疗技术开发有限公司 | 一种血液游离dna甲基化定量检测方法及其应用 |
WO2024073508A2 (fr) * | 2022-09-27 | 2024-04-04 | Guardant Health, Inc. | Procédés et compositions de quantification d'adn de cellules immunitaires |
CN116312794B (zh) * | 2023-01-09 | 2023-11-14 | 哈尔滨医科大学 | 一种融合单细胞分析方法的甲基化样本聚类方法 |
CN116949156B (zh) * | 2023-09-19 | 2023-12-08 | 美迪西普亚医药科技(上海)有限公司 | 一种基于核酸变体的通用型检测人t细胞的分析方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL1826279T3 (pl) * | 2006-02-28 | 2011-11-30 | Univ Berlin Charite | Wykrywanie i kontrola jakości regulatorowych limfocytów T dzięki analizie metylacji DNA genu FoxP3 |
-
2012
- 2012-05-25 EP EP12789375.8A patent/EP2714933A4/fr not_active Withdrawn
- 2012-05-25 WO PCT/US2012/039699 patent/WO2012162660A2/fr unknown
- 2012-05-25 CA CA2869295A patent/CA2869295A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2714933A4 (fr) | 2014-12-31 |
WO2012162660A2 (fr) | 2012-11-29 |
WO2012162660A3 (fr) | 2013-03-28 |
EP2714933A2 (fr) | 2014-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10619211B2 (en) | Methods using DNA methylation for identifying a cell or a mixture of cells for prognosis and diagnosis of diseases, and for cell remediation therapies | |
CA2869295A1 (fr) | Procedes faisant appel a la methylation de l'adn pour identifier une cellule ou un melange de cellules afin de pronostiquer et de diagnostiquer des maladies et pour effectuer des traitements de reparation cellulaire | |
Linge et al. | Low cancer stem cell marker expression and low hypoxia identify good prognosis subgroups in HPV (−) HNSCC after postoperative radiochemotherapy: a multicenter study of the DKTK-ROG | |
Claus et al. | Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia | |
EP3103046B1 (fr) | Procédé de signature de biomarqueurs, et appareil et kits associés | |
EP2569626B1 (fr) | Méthodes et compositions utilisées dans le cadre du diagnostic de maladies | |
Poage et al. | Global hypomethylation identifies loci targeted for hypermethylation in head and neck cancer | |
Gasparetto et al. | Transcription and DNA methylation patterns of blood-derived CD8+ T cells are associated with age and inflammatory bowel disease but do not predict prognosis | |
Linton et al. | Acquisition of biologically relevant gene expression data by Affymetrix microarray analysis of archival formalin-fixed paraffin-embedded tumours | |
EP2288741B1 (fr) | Signature génique prédictive et pronostique pour le cancer du poumon non à petites cellules et chimiothérapie adjuvante | |
US20190100809A1 (en) | Algorithms for disease diagnostics | |
JP2008521412A (ja) | 肺癌予後判定手段 | |
US20230366034A1 (en) | Compositions and methods for diagnosing lung cancers using gene expression profiles | |
US11208694B2 (en) | Prediction of therapeutic response in inflammatory conditions | |
AU2012345789A1 (en) | Methods of treating breast cancer with taxane therapy | |
CA2890161A1 (fr) | Combinaisons de biomarqueurs pour tumeurs colorectales | |
EP3207161A1 (fr) | Procédés et compositions pour mettre en corrélation des marqueurs génétiques avec le risque de cancer | |
JP2011509689A (ja) | Ii及びiii期結腸癌の分子病期分類並びに予後診断 | |
EP2601314A1 (fr) | Signatures géniques de pronostic pour le cancer pulmonaire à petites cellules | |
Zheng et al. | Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease | |
Wang et al. | Intermediate prognosis of 6q deletion in chronic lymphocytic leukemia | |
WO2019005764A1 (fr) | Génotype du cmh-i limitant le paysage mutationnel oncogène | |
Béné et al. | Leukemia diagnosis: today and tomorrow | |
US20150294062A1 (en) | Method for Identifying a Target Molecular Profile Associated with a Target Cell Population | |
US20210079479A1 (en) | Compostions and methods for diagnosing lung cancers using gene expression profiles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20170524 |
|
FZDE | Discontinued |
Effective date: 20210831 |